Primecap Management Co. CA Sells 257,520 Shares of CVS Health Corporation $CVS

Primecap Management Co. CA trimmed its position in CVS Health Corporation (NYSE:CVS) by 8.8% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,671,880 shares of the pharmacy operator’s stock after selling 257,520 shares during the period. Primecap Management Co. CA owned approximately 0.21% of CVS Health worth $201,433,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of CVS. Harbor Capital Advisors Inc. boosted its position in shares of CVS Health by 72.1% during the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 142 shares in the last quarter. Corundum Trust Company INC bought a new stake in shares of CVS Health in the 3rd quarter valued at $29,000. Front Row Advisors LLC raised its stake in CVS Health by 436.5% during the 2nd quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock worth $31,000 after buying an additional 371 shares during the period. Twin Peaks Wealth Advisors LLC bought a new position in CVS Health during the second quarter worth about $36,000. Finally, SOA Wealth Advisors LLC. grew its stake in CVS Health by 36.9% in the third quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock valued at $37,000 after acquiring an additional 131 shares during the period. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have recently weighed in on CVS shares. Morgan Stanley lifted their price objective on CVS Health from $89.00 to $93.00 and gave the company an “overweight” rating in a report on Wednesday, December 10th. Wall Street Zen lowered shares of CVS Health from a “buy” rating to a “hold” rating in a research note on Saturday, November 1st. Robert W. Baird increased their price objective on shares of CVS Health from $82.00 to $92.00 and gave the stock an “outperform” rating in a research report on Wednesday, December 10th. Weiss Ratings reissued a “hold (c-)” rating on shares of CVS Health in a research note on Monday, December 29th. Finally, Sanford C. Bernstein reiterated a “market perform” rating and issued a $91.00 price objective on shares of CVS Health in a report on Tuesday, January 6th. Nineteen equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $94.91.

CVS Health Trading Up 2.6%

CVS Health stock opened at $76.12 on Thursday. The stock has a 50-day simple moving average of $78.35 and a 200 day simple moving average of $77.02. The stock has a market capitalization of $96.84 billion, a P/E ratio of 55.16, a PEG ratio of 0.77 and a beta of 0.50. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.63 and a current ratio of 0.84. CVS Health Corporation has a 52 week low of $58.35 and a 52 week high of $85.15.

CVS Health (NYSE:CVS) last posted its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The business had revenue of $105.69 billion for the quarter, compared to analyst estimates of $103.67 billion. During the same period in the previous year, the firm earned $1.19 EPS. The firm’s revenue was up 8.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, February 2nd. Investors of record on Thursday, January 22nd were paid a $0.665 dividend. The ex-dividend date was Thursday, January 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 3.5%. CVS Health’s dividend payout ratio is 192.75%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.